Navigation Links
Decision Resources' Forecast of Global Tanezumab Sales Slashed Following FDA Halt of Phase III Studies
Date:10/26/2010

BURLINGTON, Mass., Oct. 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that because Phase III trials of Pfizer's tanezumab for the treatment of osteoarthritis pain were halted over U.S. Food & Drug Administration safety concerns, Decision Resources' Pharmaview 2016 global sales forecast for tanezumab has been reduced by $1.2 billion to $200 million. The decision to end the trial was made after a subset of patients in the trial required joint replacement surgery due to worsened conditions.

The discontinuation of the trial is a setback for the drug and a concern for the entire drug class, as tanezumab was the most clinically advanced agent of a family of anti-nerve growth factor (NGF) monoclonal antibodies (MAbs). Anti-NGF MAbs have garnered considerable attention from large pharmaceutical companies for the novel mechanism of action; Sanofi-Aventis (SAR164877), Johnson & Johnson (AMG-403) and Abbott (PG-110) are each in an early-stage program.

"With Lipitor, Celebrex and Viagra all facing patent expiries over the next several years, Pfizer greatly needs new agents to fill the revenue gap," said Pharmaview Analyst Michael Latwis, M.B.A. "Unfortunately, given that approval for osteoarthritis pain—the largest potential market for tanezumab—is highly unlikely, our Pharmaview model does not expect sales to reach anywhere near blockbuster status."

New Pharmaview Platform ReleasedDecision Resources has released a new delivery platform for its Pharmaview product. Pharmaview provides continually updated analysis on more than 2,100 drugs from more than 250 companies, covering 150 product classes and 14 therapy areas—complete with more than 1,200 product-level forecasts.

The new platform includes not only expanded coverage of the biopharmaceutical industry, but enhanced functionality including improved search capabilities an
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
2. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
3. FDAs Just Approved Monthly Drug Treatment, Vivitrol Could Be Game Changer, Says Countrys Largest Drug Treatment Recovery President, CRCs Jerry Rhodes; Provides Addicts One Decision A Month Instead of 30
4. Decision Resources Launches Analogue Tool To Help Pharmaceutical Companies Quickly Assess Market Opportunity
5. Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare
6. Wise Sky Highlights Their Disappointment at Emergents Decision Not to Enter the China Market
7. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
8. FDA Issues Assessments of the 510(k) Program and Use of Science in Decision-Making
9. Medco CEO to Present at the Sanford C. Bernstein & Co., LLC 26th Annual Strategic Decisions Conference 2010
10. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
11. HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013  MedVantx, ... to consumer pharmaceutical distribution channel announced today the Company ... platform to manage $1.5B in pharmaceutical products and the ... quality akin to cGMP facilities in its specialty home ... . The Company provides leading pharmaceutical manufacturers, physicians, health ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions ... of proprietary clinical grade hypothermic storage and ... and contract aseptic media manufacturer , today announced ... & Regenerative Medicine Congress 2013 this week in ... http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. Mathew, BioLife,s ...
Breaking Medicine Technology:Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
... , RALEIGH, N.C., Dec. 9 ... Head of Infectious Diseases Carl Kraus, M.D., Vice President ... with John Powers, M.D., Assistant Professor of Medicine ... considerations in anti-infective drug development. , Understanding the current ...
... SAN DIEGO, Dec. 9 Sangart, Inc., a global ... to enhance the perfusion and oxygenation of ischemic (oxygen ... initiation of a dose-finding study designed to evaluate the ... care in severely injured trauma patients with lactic acidosis ...
Cached Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3
(Date:5/23/2013)... A medical malpractice case which was filed ... by Lori Mandel, an office manager in her 50’s, ... Ms. Mandel sought the medical expertise of an ... that affected the quality of her life and her ... that her doctor rendered conservative treatment for 2 years, ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... DRE, Inc. is now offering the DRE ... upgrade older model DRE or BFW halogen headlights to ... , DRE and BFW customers can easily and affordably ... to LED with DRE’s American-made Xavier-C3 LED headlight conversion ... a bright, clean and even field of illumination with ...
(Date:5/23/2013)... May 23, 2013 In Florida, residents have ... This doesn’t mean, however, that Florida’s good luck will continue, ... . This year, he encourages residents, it is important to ... 2013, forecasters are predicting there to be a 50-percent chance ... . With hurricane season lasting from June 1 to November ...
Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... There,s little benefit to parents or baby in learning before ... new study suggests. Researchers led by Dr. James Robbins, ... 235 mothers of children aged 2 to 7 years with ... condition was identified before birth (prenatally) in 46 percent of ...
... , FRIDAY, Nov. 26 (HealthDay News) -- Most American ... the topic is far less likely to arise in homes without ... half of American households have a gun, and nearly 30 children ... owned by the child,s family or friends, according to researchers at ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay News) ... and want to keep the weight off, a new Danish ... refined carbohydrates. Based on the findings, the researchers advise ... whole-grain breads. The glycemic index (GI) is a measure of ...
... devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, ... George Washington University, and the International Vaccine Institute (IVI) ... stockpile of cholera vaccines for future humanitarian use. ... maintaining a stockpile of several million doses of cholera ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Nov. 24 ... blood cancers with bone marrow and blood stem cell transplants ... and death, a new study shows. Between the early ... the overall risk of death in an analysis of more ...
... year has brought to light both the promise and ... the most deadly form of skin cancer. Early clinical ... cancer-causing gene revealed impressive results in patients whose cancers ... short-lived, as the tumors invariably returned a few months ...
Cached Medicine News:Health News: Gun-Safety Talk a Safe Bet for All Families, Experts Say 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 2Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 4Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 2Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 3Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 4Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce large devices for vascular intervention....
Medicine Products: